{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T08:27:21Z","timestamp":1740126441981,"version":"3.37.3"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"7-8","license":[{"start":{"date-parts":[[2024,3,7]],"date-time":"2024-03-07T00:00:00Z","timestamp":1709769600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,3,7]],"date-time":"2024-03-07T00:00:00Z","timestamp":1709769600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Wien Med Wochenschr"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1007\/s10354-024-01035-x","type":"journal-article","created":{"date-parts":[[2024,3,7]],"date-time":"2024-03-07T18:15:05Z","timestamp":1709835305000},"page":"161-172","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Significance of plasma relaxin-2\u00a0levels in patients with primary hypertension and type\u00a02 diabetes mellitus","Bedeutung der Plasma-Relaxin-2-Werte bei Patienten mit prim\u00e4rer Hypertonie und Diabetes mellitus Typ\u00a02"],"prefix":"10.1007","volume":"174","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8027-2406","authenticated-orcid":false,"given":"Olena","family":"Pankova","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6838-4360","authenticated-orcid":false,"given":"Oleksii","family":"Korzh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,3,7]]},"reference":[{"key":"1035_CR1","unstructured":"World Health Organization (2020) Global Health Estimates 2019 Summary Tables: Deaths by Cause, Age And Sex, by World Bank Income Group, 2000\u20132019. https:\/\/www.who.int\/docs\/default-source\/gho-documents\/global-health-estimates\/ghe2019_cod_wbincome_2000_201933383745-a750-4d94-8491-fb209dcece6f.xlsx?sfvrsn=e7bafa8_5. Accessed 09\u00a0September 2023."},{"issue":"6","key":"1035_CR2","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/s41440-018-0034-4","volume":"41","author":"M Ohishi","year":"2018","unstructured":"Ohishi\u00a0M. Hypertension with diabetes mellitus: physiology and pathology. Hypertens Res. 2018;41(6):389\u201393.","journal-title":"Hypertens Res"},{"issue":"1","key":"1035_CR3","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1152\/physrev.00001.2012","volume":"93","author":"RA Bathgate","year":"2013","unstructured":"Bathgate\u00a0RA, Halls\u00a0ML, van der Westhuizen\u00a0ET, et\u00a0al. Relaxin family peptides and their receptors. Physiol Rev. 2013;93(1):405\u201380.","journal-title":"Physiol Rev"},{"issue":"12","key":"1035_CR4","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1096\/fj.01-0070com","volume":"15","author":"T Dschietzig","year":"2001","unstructured":"Dschietzig\u00a0T, Richter\u00a0C, Bartsch\u00a0C, et\u00a0al. The pregnancy hormone relaxin is a\u00a0player in human heart failure. Faseb\u00a0J. 2001;15(12):2187\u201395.","journal-title":"Faseb J"},{"issue":"7","key":"1035_CR5","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.3390\/jpm12071021","volume":"12","author":"A Arag\u00f3n-Herrera","year":"2022","unstructured":"Arag\u00f3n-Herrera\u00a0A, Feij\u00f3o-Band\u00edn\u00a0S, Anido-Varela\u00a0L, et\u00a0al. Relaxin\u20112 as a\u00a0Potential Biomarker in Cardiovascular Diseases. J\u00a0Pers Med. 2022;12(7):1021.","journal-title":"J Pers Med"},{"key":"1035_CR6","doi-asserted-by":"publisher","first-page":"599","DOI":"10.3389\/fphys.2017.00599","volume":"8","author":"S Feij\u00f3o-Band\u00edn","year":"2017","unstructured":"Feij\u00f3o-Band\u00edn\u00a0S, Arag\u00f3n-Herrera\u00a0A, Rodr\u00edguez-Penas\u00a0D, et\u00a0al. Relaxin\u20112 in Cardiometabolic Diseases: Mechanisms of Action and Future Perspectives. Front Physiol. 2017;8:599.","journal-title":"Front Physiol"},{"issue":"5","key":"1035_CR7","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1021\/acsptsci.3c00053","volume":"6","author":"MA Hossain","year":"2023","unstructured":"Hossain\u00a0MA, Praveen\u00a0P, Noorzi\u00a0NA, et\u00a0al. Development of Novel High-Affinity Antagonists for the Relaxin Family Peptide Receptor 1. Acs Pharmacol Transl Sci. 2023;6(5):842\u201353.","journal-title":"Acs Pharmacol Transl Sci"},{"key":"1035_CR8","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.3389\/fphys.2018.01234","volume":"9","author":"X Lian","year":"2018","unstructured":"Lian\u00a0X, Beer-Hammer\u00a0S, K\u00f6nig\u00a0GM, et\u00a0al. RXFP1 Receptor Activation by Relaxin\u20112 Induces Vascular Relaxation in Mice via a\u00a0G\u03b1i2-Protein\/PI3K\u00df\/\u03b3\/Nitric Oxide-Coupled Pathway. Front Physiol. 2018;9:1234.","journal-title":"Front Physiol"},{"issue":"12","key":"1035_CR9","doi-asserted-by":"publisher","first-page":"F1355","DOI":"10.1152\/ajprenal.00407.2014","volume":"307","author":"JM Sasser","year":"2014","unstructured":"Sasser\u00a0JM, Cunningham\u00a0MW Jr, Baylis\u00a0C. Serelaxin reduces oxidative stress and asymmetric dimethylarginine in angiotensin\u00a0II-induced hypertension. Am J Physiol Renal Physiol. 2014;307(12):F1355\u2013F62.","journal-title":"Am J Physiol Renal Physiol"},{"issue":"2","key":"1035_CR10","doi-asserted-by":"publisher","first-page":"e1002248","DOI":"10.1371\/journal.pmed.1002248","volume":"14","author":"VK Snowdon","year":"2017","unstructured":"Snowdon\u00a0VK, Lachlan\u00a0NJ, Hoy\u00a0AM, et\u00a0al. Serelaxin as a\u00a0potential treatment for renal dysfunction in cirrhosis: Preclinical evaluation and results of a\u00a0randomized phase\u00a02\u00a0trial. PLoS Med. 2017;14(2):e1002248.","journal-title":"PLoS Med"},{"issue":"5","key":"1035_CR11","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1161\/HYPERTENSIONAHA.109.149369","volume":"55","author":"Q Xu","year":"2010","unstructured":"Xu\u00a0Q, Chakravorty\u00a0A, Bathgate\u00a0RA, Dart\u00a0AM, Du\u00a0XJ. Relaxin therapy reverses large artery remodeling and improves arterial compliance in senescent spontaneously hypertensive rats. Hypertension. 2010;55(5):1260\u20136.","journal-title":"Hypertension"},{"issue":"7","key":"1035_CR12","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1093\/eurheartj\/eht459","volume":"35","author":"P Ponikowski","year":"2014","unstructured":"Ponikowski\u00a0P, Mitrovic\u00a0V, Ruda\u00a0M, et\u00a0al. A\u00a0randomized, double-blind, placebo-controlled, multicentre study to assess haemodynamic effects of serelaxin in patients with acute heart failure. Eur Heart\u00a0J. 2014;35(7):431\u201341.","journal-title":"Eur Heart J"},{"issue":"9860","key":"1035_CR13","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S0140-6736(12)61855-8","volume":"381","author":"JR Teerlink","year":"2013","unstructured":"Teerlink\u00a0JR, Cotter\u00a0G, Davison\u00a0BA, et\u00a0al. Serelaxin, recombinant human relaxin\u20112, for treatment of acute heart failure (RELAX-AHF): a\u00a0randomised, placebo-controlled trial. Lancet. 2013;381(9860):29\u201339.","journal-title":"Lancet"},{"issue":"8","key":"1035_CR14","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1056\/NEJMoa1801291","volume":"381","author":"M Metra","year":"2019","unstructured":"Metra\u00a0M, Teerlink\u00a0JR, Cotter\u00a0G, et\u00a0al. Effects of Serelaxin in Patients with Acute Heart Failure. N\u00a0Engl J Med. 2019;381(8):716\u201326.","journal-title":"N Engl J Med"},{"issue":"1","key":"1035_CR15","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1093\/cvr\/cvz345","volume":"117","author":"D Corcoran","year":"2021","unstructured":"Corcoran\u00a0D, Radjenovic\u00a0A, Mordi\u00a0IR, et\u00a0al. Vascular effects of serelaxin in patients with stable coronary artery disease: a\u00a0randomized placebo-controlled trial. Cardiovasc Res. 2021;117(1):320\u20139.","journal-title":"Cardiovasc Res"},{"issue":"6","key":"1035_CR16","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1111\/bcp.12572","volume":"79","author":"Z Kobalava","year":"2015","unstructured":"Kobalava\u00a0Z, Villevalde\u00a0S, Kotovskaya\u00a0Y, et\u00a0al. Pharmacokinetics of serelaxin in patients with hepatic impairment: a\u00a0single-dose, open-label, parallel group study. Br J Clin Pharmacol. 2015;79(6):937\u201345.","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"1035_CR17","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1186\/s13063-020-4203-9","volume":"21","author":"FJ Gifford","year":"2020","unstructured":"Gifford\u00a0FJ, Dunne\u00a0PDJ, Weir\u00a0G, et\u00a0al. A\u00a0phase\u00a02 randomised controlled trial of serelaxin to lower portal pressure in cirrhosis (STOPP). Trials. 2020;21(1):260.","journal-title":"Trials"},{"issue":"4","key":"1035_CR18","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1002\/jcph.607","volume":"56","author":"M Dahlke","year":"2016","unstructured":"Dahlke\u00a0M, Halabi\u00a0A, Canadi\u00a0J, Tsubouchi\u00a0C, Machineni\u00a0S, Pang\u00a0Y. Pharmacokinetics of serelaxin in patients with severe renal impairment or end-stage renal disease requiring hemodialysis: A\u00a0single-dose, open-label, parallel-group study. J\u00a0Clin Pharmacol. 2016;56(4):474\u201383.","journal-title":"J Clin Pharmacol"},{"issue":"4","key":"1035_CR19","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1002\/art.24380","volume":"60","author":"D Khanna","year":"2009","unstructured":"Khanna\u00a0D, Clements\u00a0PJ, Furst\u00a0DE, et\u00a0al. Recombinant human relaxin in the treatment of systemic sclerosis with diffuse cutaneous involvement: a\u00a0randomized, double-blind, placebo-controlled trial. Arthritis Rheum. 2009;60(4):1102\u201311.","journal-title":"Arthritis Rheum"},{"key":"1035_CR20","unstructured":"Sonaglia F, Milia P, Caserio M, et\u00a0al. Efficacy and safety of oral porcine relaxin (pRLX) in adjunct to physical exercise in the treatment of peripheral arterial disease (PAD). Ital J Anat Embryol. 2013;118(1 Suppl):84\u201391."},{"key":"1035_CR21","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1080\/08037050902864086","volume":"18(1\u20132","author":"O Gedikli","year":"2009","unstructured":"Gedikli\u00a0O, Yilmaz\u00a0H, Kiris\u00a0A, et\u00a0al. Circulating levels of relaxin and its relation to cardiovascular function in patients with hypertension. Blood Press. 2009;18(1\u20132:68\u201373.","journal-title":"Blood Press"},{"key":"1035_CR22","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1016\/j.clinbiochem.2013.08.007","volume":"46(16\u201317","author":"X Zhang","year":"2013","unstructured":"Zhang\u00a0X, Zhu\u00a0M, Zhao\u00a0M, et\u00a0al. The plasma levels of relaxin\u20112 and relaxin\u20113 in patients with diabetes. Clin Biochem. 2013;46(16\u201317:1713\u20136.","journal-title":"Clin Biochem"},{"issue":"3","key":"1035_CR23","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.diabres.2007.10.017","volume":"79","author":"B Szepietowska","year":"2008","unstructured":"Szepietowska\u00a0B, Gorska\u00a0M, Szelachowska\u00a0M. Plasma relaxin concentration is related to beta-cell function and insulin sensitivity in women with type\u00a02 diabetes mellitus. Diabetes Res Clin Pract. 2008;79(3):e1\u2013e3.","journal-title":"Diabetes Res Clin Pract"},{"issue":"2","key":"1035_CR24","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1536\/ihj.17-082","volume":"59","author":"X Gao","year":"2018","unstructured":"Gao\u00a0X, Li\u00a0H, Wang\u00a0P, Chen\u00a0H. Decreased Serum Relaxin\u20112 Is Correlated with Impaired Islet \u03b2\u2011Cell Function in Patients with Unstable Angina and Abnormal Glucose Metabolism. Int Heart\u00a0J. 2018;59(2):272\u20138.","journal-title":"Int Heart J"},{"issue":"06","key":"1035_CR25","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1210\/jcem-41-6-1065","volume":"41","author":"GD Bryant","year":"1975","unstructured":"Bryant\u00a0GD, Panter\u00a0ME, Stelmasiak\u00a0T. Immunoreactive relaxin in human serum during the menstrual cycle. J\u00a0Clin Endocrinol Metab. 1975;41(06):1065\u20139.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"1035_CR26","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1111\/jog.13226","volume":"43","author":"S Nose-Ogura","year":"2017","unstructured":"Nose-Ogura\u00a0S, Yoshino\u00a0O, Yamada-Nomoto\u00a0K, et\u00a0al. Oral contraceptive therapy reduces serum relaxin\u20112 in elite female athletes. J\u00a0Obstet Gynaecol Res. 2017;43(3):530\u20135.","journal-title":"J Obstet Gynaecol Res"},{"key":"1035_CR27","first-page":"006","volume":"1","author":"E Casey","year":"2018","unstructured":"Casey\u00a0E, Anderson\u00a0T, Wideman\u00a0L, et\u00a0al. Optimal Paradigms for Measuring Peak Serum Relaxin in Eumenorrheic, Active Females. Reprod Med Int. 2018;1:6.","journal-title":"Reprod Med Int"},{"key":"1035_CR28","doi-asserted-by":"crossref","unstructured":"Williams B, Mancia G, Spiering W, et\u00a0al. 2018 ESC\/ESH Guidelines for the management of arterial hypertension [published correction appears in Eur Heart J. 2019 Feb 1;40(5):475]. Eur Heart J. 2018;39(33):3021\u2013104.","DOI":"10.1093\/eurheartj\/ehy339"},{"key":"1035_CR29","doi-asserted-by":"crossref","unstructured":"American Diabetes Association Standards of Medical Care in Diabetes\u20142022 Abridged for Primary Care Providers. Clin. Diabetes. 2022;40(1):10\u201338.","DOI":"10.2337\/cd22-as01"},{"issue":"1","key":"1035_CR30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/kisup.2012.73","volume":"3","author":"Kidney Disease","year":"2013","unstructured":"Kidney Disease. Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney. Dis Kidney Inter Suppl. 2013;3(1):1\u2013150.","journal-title":"Dis Kidney Inter Suppl"},{"key":"1035_CR31","unstructured":"World Health Organization Obesity: preventing and managing the global epidemic. Report of a\u00a0WHO Consultation. World Health Organ Tech Rep Ser. 2000;894:i\u2013xii, 1\u2013253."},{"key":"1035_CR32","unstructured":"World Health Organization Physical status: the use and interpretation of anthropometry. Report of a\u00a0WHO. Ser, Vol. 854. Committee. World Health Organ Tech Rep: Expert; 1995. pp.\u00a01\u2013452."},{"key":"1035_CR33","unstructured":"World Health Organization. Noncommunicable Diseases and Mental Health Cluster (2020) WHO STEPS Surveillance Manual: the WHO STEPwise approach to noncommunicable disease risk factor surveillance. https:\/\/www.who.int\/docs\/default-source\/ncds\/ncd-surveillance\/steps\/steps-manual.pdf?sfvrsn=c281673d_5. Accessed 09\u00a0September 2023."},{"issue":"2","key":"1035_CR34","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1530\/jrf.0.0480389","volume":"48","author":"GD Bryant","year":"1976","unstructured":"Bryant\u00a0GD, Sassin\u00a0JF, Weitzman\u00a0ED, et\u00a0al. Relaxin immunoactivity in human plasma during a\u00a024-hr period. J\u00a0Reprod Fertil. 1976;48(2):389\u201392.","journal-title":"J Reprod Fertil"},{"issue":"2","key":"1035_CR35","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1002\/ejhf.611","volume":"19","author":"M Pintalhao","year":"2017","unstructured":"Pintalhao\u00a0M, Castro-Chaves\u00a0P, Vasques-Novoa\u00a0F, et\u00a0al. Relaxin serum levels in acute heart failure are associated with pulmonary hypertension and right heart overload. Eur J Heart Fail. 2017;19(2):218\u201325.","journal-title":"Eur J Heart Fail"},{"issue":"2","key":"1035_CR36","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.ejheart.2004.07.010","volume":"7","author":"M Kupari","year":"2005","unstructured":"Kupari\u00a0M, Mikkola\u00a0TS, Turto\u00a0H, et\u00a0al. Is the pregnancy hormone relaxin an important player in human heart failure? Eur J Heart Fail. 2005;7(2):195\u20138.","journal-title":"Eur J Heart Fail"},{"key":"1035_CR37","doi-asserted-by":"publisher","first-page":"22287","DOI":"10.1038\/s41598-022-26836-1","volume":"12(1","author":"A Arag\u00f3n-Herrera","year":"2022","unstructured":"Arag\u00f3n-Herrera\u00a0A, Couselo-Seijas\u00a0M, Feij\u00f3o-Band\u00edn\u00a0S, et\u00a0al. Relaxin\u20112 plasma levels in atrial fibrillation are linked to inflammation and oxidative stress markers. Sci Rep. 2022;12(1:22287.","journal-title":"Sci Rep"},{"issue":"2","key":"1035_CR38","doi-asserted-by":"publisher","first-page":"128","DOI":"10.3928\/01477447-20130122-06","volume":"36","author":"JM Wolf","year":"2013","unstructured":"Wolf\u00a0JM, Cameron\u00a0KL, Clifton\u00a0KB, et\u00a0al. Serum relaxin levels in young athletic men are comparable with those in women. Orthopedics. 2013;36(2):128\u201331.","journal-title":"Orthopedics"},{"issue":"10","key":"1035_CR39","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1177\/0363546511413378","volume":"39","author":"JL Dragoo","year":"2011","unstructured":"Dragoo\u00a0JL, Castillo\u00a0TN, Braun\u00a0HJ, et\u00a0al. Prospective correlation between serum relaxin concentration and anterior cruciate ligament tears among elite collegiate female athletes. Am J Sports Med. 2011;39(10):2175\u201380.","journal-title":"Am J Sports Med"},{"issue":"4","key":"1035_CR40","doi-asserted-by":"publisher","first-page":"e724","DOI":"10.3928\/01477447-20160421-01","volume":"39","author":"BD Owens","year":"2016","unstructured":"Owens\u00a0BD, Cameron\u00a0KL, Clifton\u00a0KB, et\u00a0al. Association Between Serum Relaxin and Subsequent Shoulder Instability. Orthopedics. 2016;39(4):e724\u2013e8.","journal-title":"Orthopedics"},{"issue":"6","key":"1035_CR41","first-page":"598","volume":"113","author":"J Nonhoff","year":"2017","unstructured":"Nonhoff\u00a0J, Ricke-Hoch\u00a0M, Mueller\u00a0M, et\u00a0al. Serelaxin treatment promotes adaptive hypertrophy but does not prevent heart failure in experimental peripartum cardiomyopathy. Cardiovasc Res. 2017;113(6):598\u2013608.","journal-title":"Cardiovasc Res"},{"key":"1035_CR42","first-page":"19","volume":"3","author":"JL Dragoo","year":"2011","unstructured":"Dragoo\u00a0JL, Castillo\u00a0TN, Korotkova\u00a0TA, et\u00a0al. Trends in serum relaxin concentration among elite collegiate female athletes. Int J Womens Health. 2011;3:19\u201324.","journal-title":"Int J Womens Health"},{"issue":"11","key":"1035_CR43","first-page":"2164","volume":"32","author":"N Giordano","year":"2005","unstructured":"Giordano\u00a0N, Papakostas\u00a0P, Lucani\u00a0B, et\u00a0al. Serum relaxin in systemic sclerosis. J\u00a0Rheumatol. 2005;32(11):2164\u20136.","journal-title":"J Rheumatol"},{"issue":"2","key":"1035_CR44","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1023\/B:BREA.0000041622.30169.16","volume":"87","author":"C Binder","year":"2004","unstructured":"Binder\u00a0C, Simon\u00a0A, Binder\u00a0L, et\u00a0al. Elevated concentrations of serum relaxin are associated with metastatic disease in breast cancer patients. Breast Cancer Res Treat. 2004;87(2):157\u201366.","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"1035_CR45","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.ejim.2003.11.009","volume":"15","author":"S Kr\u00fcger","year":"2004","unstructured":"Kr\u00fcger\u00a0S, Graf\u00a0J, Merx\u00a0MW, et\u00a0al. Relaxin kinetics during dynamic exercise in patients with chronic heart failure. Eur J Intern Med. 2004;15(1):54\u20136.","journal-title":"Eur J Intern Med"},{"issue":"4","key":"1035_CR46","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1007\/s11999-013-2960-4","volume":"472","author":"JM Wolf","year":"2014","unstructured":"Wolf\u00a0JM, Scher\u00a0DL, Etchill\u00a0EW, et\u00a0al. Relationship of relaxin hormone and thumb carpometacarpal joint arthritis. Clin Orthop Relat Res. 2014;472(4):1130\u20137.","journal-title":"Clin Orthop Relat Res"},{"issue":"6","key":"1035_CR47","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1080\/09513590701447998","volume":"23","author":"T Sch\u00f6ndorf","year":"2007","unstructured":"Sch\u00f6ndorf\u00a0T, L\u00fcbben\u00a0G, Hoopmann\u00a0M, et\u00a0al. Relaxin expression correlates significantly with serum fibrinogen variation in response to antidiabetic treatment in women with type\u00a02 diabetes mellitus. Gynecol Endocrinol. 2007;23(6):356\u201360.","journal-title":"Gynecol Endocrinol"},{"key":"1035_CR48","doi-asserted-by":"crossref","unstructured":"Samuel CS, Royce SG, Hewitson TD, Denton KM, Cooney TE, Bennett RG. Anti-fibrotic actions of relaxin [published correction appears in Br J Pharmacol. 2017;174(24):4836]. Br J Pharmacol. 2017;174(10):962\u2013976.","DOI":"10.1111\/bph.13529"},{"issue":"4","key":"1035_CR49","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/j.jhsa.2013.01.019","volume":"38","author":"JM Wolf","year":"2013","unstructured":"Wolf\u00a0JM, Williams\u00a0AE, Delaronde\u00a0S, et\u00a0al. Relationship of serum relaxin to generalized and trapezial-metacarpal joint laxity. J\u00a0Hand Surg Am. 2013;38(4):721\u20138.","journal-title":"J Hand Surg Am"},{"issue":"3","key":"1035_CR50","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1111\/jch.12260","volume":"16","author":"DP Papadopoulos","year":"2014","unstructured":"Papadopoulos\u00a0DP, Makris\u00a0T, Perrea\u00a0D, et\u00a0al. Apelin and relaxin plasma levels in young healthy offspring of patients with essential hypertension. J\u00a0Clin Hypertens (greenwich). 2014;16(3):198\u2013201.","journal-title":"J Clin Hypertens (greenwich)"},{"issue":"5","key":"1035_CR51","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1111\/jch.12075","volume":"15","author":"DP Papadopoulos","year":"2013","unstructured":"Papadopoulos\u00a0DP, Mourouzis\u00a0I, Faselis\u00a0C, et\u00a0al. Masked hypertension and atherogenesis: the impact of apelin and relaxin plasma levels. J\u00a0Clin Hypertens (greenwich). 2013;15(5):333\u20136.","journal-title":"J Clin Hypertens (greenwich)"},{"issue":"1","key":"1035_CR52","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1111\/jch.13449","volume":"21","author":"E Sanidas","year":"2019","unstructured":"Sanidas\u00a0E, Tsakalis\u00a0K, Papadopoulos\u00a0DP, et\u00a0al. The impact of apelin and relaxin plasma levels in masked hypertension and white coat hypertension. J\u00a0Clin Hypertens (greenwich). 2019;21(1):48\u201352.","journal-title":"J Clin Hypertens (greenwich)"},{"issue":"1","key":"1035_CR53","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1159\/000443182","volume":"91","author":"A Bonanno","year":"2016","unstructured":"Bonanno\u00a0A, Riccobono\u00a0L, Bonsignore\u00a0MR, et\u00a0al. Relaxin in Obstructive Sleep Apnea: Relationship with Blood Pressure and Inflammatory Mediators. Respiration. 2016;91(1):56\u201362.","journal-title":"Respiration"},{"issue":"3","key":"1035_CR54","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1007\/s12020-017-1354-x","volume":"57","author":"AY Lopez","year":"2017","unstructured":"Lopez\u00a0AY, Dereke\u00a0J, Landin-Olsson\u00a0M, et\u00a0al. Plasma levels of relaxin\u20112 are higher and correlated to C\u2011peptide levels in early gestational diabetes mellitus. Endocrine. 2017;57(3):545\u20137.","journal-title":"Endocrine"},{"issue":"3","key":"1035_CR55","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1007\/BF03346460","volume":"32","author":"P Wang","year":"2009","unstructured":"Wang\u00a0P, Li\u00a0HW, Wang\u00a0YP, Chen\u00a0H, Zhang\u00a0P. Effects of recombinant human relaxin upon proliferation of cardiac fibroblast and synthesis of collagen under high glucose condition. J\u00a0Endocrinol Invest. 2009;32(3):242\u20137.","journal-title":"J Endocrinol Invest"},{"issue":"9","key":"1035_CR56","doi-asserted-by":"publisher","first-page":"3251","DOI":"10.2337\/db13-0033","volume":"62","author":"JS Bonner","year":"2013","unstructured":"Bonner\u00a0JS, Lantier\u00a0L, Hocking\u00a0KM, et\u00a0al. Relaxin treatment reverses insulin resistance in mice fed a\u00a0high-fat diet. Diabetes. 2013;62(9):3251\u201360.","journal-title":"Diabetes"},{"issue":"12","key":"1035_CR57","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1042\/CS20130105","volume":"125","author":"A Bitto","year":"2013","unstructured":"Bitto\u00a0A, Irrera\u00a0N, Minutoli\u00a0L, et\u00a0al. Relaxin improves multiple markers of wound healing and ameliorates the disturbed healing pattern of genetically diabetic mice. Clin Sci (lond). 2013;125(12):575\u201385.","journal-title":"Clin Sci (lond)"},{"issue":"2","key":"1035_CR58","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1074\/jbc.M114.589325","volume":"290","author":"S Singh","year":"2015","unstructured":"Singh\u00a0S, Simpson\u00a0RL, Bennett\u00a0RG. Relaxin activates peroxisome proliferator-activated receptor \u03b3 (PPAR\u03b3) through a\u00a0pathway involving PPAR\u03b3 coactivator 1\u03b1 (PGC1\u03b1). J\u00a0Biol Chem. 2015;290(2):950\u20139.","journal-title":"J Biol Chem"},{"key":"1035_CR59","doi-asserted-by":"publisher","first-page":"501","DOI":"10.3389\/fphar.2018.00501","volume":"9","author":"HH Ng","year":"2018","unstructured":"Ng\u00a0HH, Leo\u00a0CH, Parry\u00a0LJ, Ritchie\u00a0RH. Relaxin as a\u00a0Therapeutic Target for the Cardiovascular Complications of Diabetes. Front Pharmacol. 2018;9:501.","journal-title":"Front Pharmacol"},{"key":"1035_CR60","doi-asserted-by":"publisher","first-page":"39604","DOI":"10.1038\/srep39604","volume":"7","author":"HH Ng","year":"2017","unstructured":"Ng\u00a0HH, Leo\u00a0CH, Prakoso\u00a0D, Qin\u00a0C, Ritchie\u00a0RH, Parry\u00a0LJ. Serelaxin treatment reverses vascular dysfunction and left ventricular hypertrophy in a\u00a0mouse model of Type\u00a01 diabetes. Sci Rep. 2017;7:39604.","journal-title":"Sci Rep"},{"issue":"1","key":"1035_CR61","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1159\/000368484","volume":"40","author":"TB Dschietzig","year":"2015","unstructured":"Dschietzig\u00a0TB, Krause-Relle\u00a0K, Hennequin\u00a0M, et\u00a0al. Relaxin\u20112 does not ameliorate nephropathy in an experimental model of type\u20111 diabetes. Kidney Blood Press Res. 2015;40(1):77\u201388.","journal-title":"Kidney Blood Press Res"},{"issue":"9","key":"1035_CR62","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.2174\/0929866511320090009","volume":"20","author":"SE Wong","year":"2013","unstructured":"Wong\u00a0SE, Samuel\u00a0CS, Kelly\u00a0DJ, et\u00a0al. The anti-fibrotic hormone relaxin is not reno-protective, despite being active, in an experimental model of type\u00a01 diabetes. Protein Pept Lett. 2013;20(9):1029\u201338.","journal-title":"Protein Pept Lett"},{"issue":"2","key":"1035_CR63","doi-asserted-by":"publisher","first-page":"786","DOI":"10.3390\/ijms23020786","volume":"23","author":"G Fahed","year":"2022","unstructured":"Fahed\u00a0G, Aoun\u00a0L, Bou Zerdan\u00a0M, Allam\u00a0S, Bou Zerdan\u00a0M, Bouferraa\u00a0Y, Assi\u00a0HI. Metabolic Syndrome: Updates on Pathophysiology and Management in 2021. Int J Mol Sci. 2022;23(2):786.","journal-title":"Int J Mol Sci"},{"key":"1035_CR64","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.phrs.2019.04.009","volume":"144","author":"A Arag\u00f3n-Herrera","year":"2019","unstructured":"Arag\u00f3n-Herrera\u00a0A, Feij\u00f3o-Band\u00edn\u00a0S, Abella\u00a0V, et\u00a0al. Serelaxin (recombinant human relaxin-2) treatment affects the endogenous synthesis of long chain poly-unsaturated fatty acids and induces substantial alterations of lipidome and metabolome profiles in rat cardiac tissue. Pharmacol Res. 2019;144:51\u201365.","journal-title":"Pharmacol Res"},{"issue":"7","key":"1035_CR65","doi-asserted-by":"publisher","first-page":"e21737","DOI":"10.1096\/fj.202002620RR","volume":"35","author":"A Arag\u00f3n-Herrera","year":"2021","unstructured":"Arag\u00f3n-Herrera\u00a0A, Feij\u00f3o-Band\u00edn\u00a0S, Mora\u00f1a-Fern\u00e1ndez\u00a0S, et\u00a0al. Relaxin has beneficial effects on liver lipidome and metabolic enzymes. Faseb\u00a0J. 2021;35(7):e21737.","journal-title":"Faseb J"},{"issue":"12","key":"1035_CR66","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1111\/j.1463-1326.2010.01302.x","volume":"12","author":"BM McGowan","year":"2010","unstructured":"McGowan\u00a0BM, Minnion\u00a0JS, Murphy\u00a0KG, et\u00a0al. Central and peripheral administration of human relaxin\u20112 to adult male rats inhibits food intake. Diabetes Obes Metab. 2010;12(12):1090\u20136.","journal-title":"Diabetes Obes Metab"},{"key":"1035_CR67","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1161\/HYPERTENSIONAHA.117.09081","volume":"69(6","author":"C Borghi","year":"2017","unstructured":"Borghi\u00a0C, Cicero\u00a0AFG. Serum Uric Acid and Cardiometabolic Disease: Another Brick in the Wall? Hypertension. 2017;69(6:1011\u20133.","journal-title":"Hypertension"}],"container-title":["Wiener Medizinische Wochenschrift"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10354-024-01035-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10354-024-01035-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10354-024-01035-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,30]],"date-time":"2024-04-30T09:05:14Z","timestamp":1714467914000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10354-024-01035-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,7]]},"references-count":67,"journal-issue":{"issue":"7-8","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["1035"],"URL":"https:\/\/doi.org\/10.1007\/s10354-024-01035-x","relation":{},"ISSN":["0043-5341","1563-258X"],"issn-type":[{"type":"print","value":"0043-5341"},{"type":"electronic","value":"1563-258X"}],"subject":[],"published":{"date-parts":[[2024,3,7]]},"assertion":[{"value":"9 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"O.\u00a0Pankova and O.\u00a0Korzh declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants or on human tissue were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1975 Helsinki declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants included in the study. The study protocol was approved by the Ethics Committee of the Medical-Sanitary Base of JSC \u201cKharkiv Tractor Plant\u201d (date of approval: 21\u00a0September 2021).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standards"}}]}}